Ann: Pharmaceutical protection contract using Dat, page-12

re: Ann: Pharmaceutical protection contract u... Yeah, as stated I agree that the lack of figures is annoying and I guess we'll have to wait to see what kind of guidance we're given come the next report.

I disagree that the lack of figures is necessarily an attempt to hide that we're not making any real money out of these new contracts though.

It could very well be that you're right, and we aren't making any real money out of them. But I'll wait and see before I get excited or disappointed about that.

In the interim what I'm liking is the potential shown through these contracts. We appear to be garnering market acceptance in different industries, and that can't be a bad thing.